Insider · CIK 0001573722

Hoberman Kenneth

Reports to the SEC for 3 companies · MORRISVILLE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001573722

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	TGTXTG THERAPEUTICS, INC. · Stock Tracking UnitA Award	Director	AAward	+8,325 sh	—	—	8,325
2026-06-11	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+35K sh	—	—	168,140
2025-06-12	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+30K sh	—	—	133,140
2025-06-12	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+14.7K sh	—	—	279,653
2024-06-19	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+22.3K sh	—	—	264,935
2024-06-13	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+30K sh	—	—	103,140
2023-09-28	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	—	—	242,685
2023-06-16	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+18K sh	—	—	73,140
2022-07-20	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+43.7K sh	—	—	222,685
2022-05-12	NVCTNuvectis Pharma, Inc.P Purchase	Director	PPurchase	+6,000 sh	$17.40	+$104K	55,140
2022-04-01	NVCTNuvectis Pharma, Inc. · Stock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-18	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	—	—	178,953
2020-06-22	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+15K sh	—	—	158,953
2020-06-10	STEMLINE THERAPEUTICS INCA Award	Chief Operating Officer	AAward	+600K sh	—	—	1,374,352
2020-06-10	STEMLINE THERAPEUTICS INCU Disposition from Tender	Chief Operating Officer	UDisposition from Tender	−1.37M sh	—	—	0
2020-06-10	STEMLINE THERAPEUTICS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−44.1K sh	—	—	0
2020-06-10	STEMLINE THERAPEUTICS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−25K sh	—	—	0
2020-03-10	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−16.7K sh	$4.91	−$82K	771,764
2020-03-09	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−9,487 sh	$5.08	−$48.2K	788,468
2020-02-25	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−11.5K sh	$6.42	−$74.1K	797,955
2020-02-10	STEMLINE THERAPEUTICS INCA Award	Chief Operating Officer	AAward	+208K sh	—	—	809,502
2020-01-22	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−22.1K sh	$7.02	−$155K	601,085
2020-01-08	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−13.2K sh	$10.37	−$137K	623,224
2019-12-27	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−2,022 sh	$10.48	−$21.2K	636,452
2019-12-26	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−15.5K sh	$10.75	−$167K	638,474
2019-12-24	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−24.5K sh	$10.97	−$269K	653,968
2019-12-23	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−4,319 sh	$10.58	−$45.7K	678,445
2019-09-17	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+27K sh	—	—	143,953
2019-06-26	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−12.5K sh	$14.77	−$185K	682,764
2019-06-25	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−25.5K sh	$15.07	−$384K	695,272
2019-06-24	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−9,107 sh	$15.49	−$141K	720,772
2019-06-12	STEMLINE THERAPEUTICS INCStock Options (right to buy)G Gift	Chief Operating Officer	GGift	−18.1K sh	—	—	0
2019-06-12	STEMLINE THERAPEUTICS INCStock Options (right to buy)G Gift	Chief Operating Officer	GGift	−97.6K sh	—	—	0
2019-06-12	STEMLINE THERAPEUTICS INCStock Options (right to buy)G Gift	Chief Operating Officer	GGift	−132K sh	—	—	0
2019-06-12	STEMLINE THERAPEUTICS INCStock Options (right to buy)G Gift	Chief Operating Officer	GGift	−18.1K sh	—	—	0
2019-06-12	STEMLINE THERAPEUTICS INCStock Options (right to buy)G Gift	Chief Operating Officer	GGift	−75K sh	—	—	0
2019-05-14	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−25.8K sh	$14.27	−$368K	729,879
2019-03-12	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−981 sh	$11.04	−$10.8K	755,696
2019-03-11	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−25.1K sh	$11.11	−$279K	756,677
2019-03-07	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−2,995 sh	$11.36	−$34K	781,778
2019-02-25	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−10.6K sh	$12.05	−$127K	784,773
2019-02-06	STEMLINE THERAPEUTICS INCA Award	Chief Operating Officer	AAward	+135K sh	—	—	781,723
2019-02-06	STEMLINE THERAPEUTICS INCA Award	Chief Operating Officer	AAward	+13.6K sh	—	—	795,330
2019-01-08	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−13.5K sh	$10.15	−$138K	646,652
2018-11-26	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−26.3K sh	$11.85	−$312K	659,738
2018-09-12	STEMLINE THERAPEUTICS INCA Award	Chief Operating Officer	AAward	+175K sh	—	—	686,034
2018-09-12	STEMLINE THERAPEUTICS INCA Award	Chief Operating Officer	AAward	+100K sh	—	—	511,034
2018-06-26	TGTXTG THERAPEUTICS, INC.A Award	Director	AAward	+15K sh	—	—	116,905
2018-03-13	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−12.7K sh	$16.82	−$214K	409,594
2018-03-12	STEMLINE THERAPEUTICS INCS Sale	Chief Operating Officer	SSale	−3,299 sh	$18.24	−$60.2K	422,340

Recent filings

Accepted (ET)
Jun 154
Hoberman Kenneth0001437749-26-020676
SEC(opens sec.gov)
Jun 124
Hoberman Kenneth0001104659-26-073461
SEC(opens sec.gov)
Jun 164
Hoberman Kenneth0001437749-25-020543
SEC(opens sec.gov)
Jun 124
Hoberman Kenneth0001104659-25-058915
SEC(opens sec.gov)
Jun 204
Hoberman Kenneth0001437749-24-020849
SEC(opens sec.gov)
Jun 134
Hoberman Kenneth0001104659-24-071285
SEC(opens sec.gov)
Sep 294
Hoberman Kenneth0001104659-23-105394
SEC(opens sec.gov)
Jun 204
Hoberman Kenneth0001104659-23-072605
SEC(opens sec.gov)
Jul 224
Hoberman Kenneth0001104659-22-082020
SEC(opens sec.gov)
May 164
Hoberman Kenneth0001104659-22-060913
SEC(opens sec.gov)
Apr 54
Hoberman Kenneth0001104659-22-042820
SEC(opens sec.gov)
Jun 224
Hoberman Kenneth0001104659-21-084258
SEC(opens sec.gov)
Jun 244
Hoberman Kenneth0001104659-20-076545
SEC(opens sec.gov)
Jun 104
Hoberman Kenneth0001104659-20-071835
SEC(opens sec.gov)
Mar 134
Hoberman Kenneth0001104659-20-033491
SEC(opens sec.gov)
Feb 284
Hoberman Kenneth0001104659-20-027397
SEC(opens sec.gov)

Companies

Address

3020 CARRINGTON MILL BLVD, SUITE 475

MORRISVILLE, NC, 27560